ReviewDie Anaesthesiologie2025
[Quality assurance of extracorporeal membrane oxygenation (ECMO) - optimization through evidence-based quality indicators].
Review in Die Anaesthesiologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe high mortality rates associated with extracorporeal membrane oxygenation (ECMO) treatment in Germany compared to international benchmarks indicate potential issues with treatment quality and require an analysis of the quality assurance of ECMO treatment.
objectiveFirstly, this article aims to analyze whether the legal requirements for quality standards of complex medical and technical measures as well as the demands of professional societies for guideline adherence in treatment can currently be verified. Secondly, the goal is to develop cross-procedural, evidence-based quality indicators (QI) for a specific comprehensive quality management system (QMS) for ECMO treatment in Germany, to enable a comparison of centers and a continuous improvement process. MATERIAL AND
methodsA review of the literature concerning quality management for ECMO treatment was conducted. Data from relevant quality reporting platforms were analyzed. Strong recommendations from guidelines on ECMO treatment were used to derive specific cross-procedural QIs. These were categorized by structural, process and outcome quality and compared with existing registry data.
resultsThree data registers for ECMO treatment in Germany were identified, revealing a lack of specific QIs and effective monitoring of guideline adherence. Consequently, a comprehensive analysis of treatment quality is currently not possible. From the guideline recommendations 22 QIs were defined to be integrated into a standardized quality management system for ECMO treatment.
conclusionImplementing evidence-based QIs can enhance quality assurance, improve transparency regarding legal requirements and guideline adherence, while also facilitating continuous improvement and enabling benchmarking. Recommendations on the indications and minimum implementation numbers can be made based on evaluation of the data obtained.
Indexed as
Identifiers
39992391What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.